Oncotrone - analogs
Components: Mitoxantrone |
|||||||||
Pharmgroups: Other antitumor agents || Anthracyclines and related compounds |
|||||||||
| Prices in pharmacies: 43.5-44€ Instructions Oncotrone | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Pentobarbital ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Mitoxantron-LANS | 23.4€ |
| ≈100% | neutral Mitoxantron | — |
| ≈100% | neutral Mitoxantron hydrochloride | — |
| ≈100% | neutral Mitoxantron AWD 25 | — |
| ≈100% | neutral Mitoxantron AWD | — |
| ≈100% | neutral Novantrone | — |
| ≈100% | neutral Mitolek | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 62% — Farmorubicin neutral [Epirubicin]
- 61% — Epilek neutral [Epirubicin]
- 61% — Epirubicin neutral [Epirubicin]
- 61% 11.7€ Farmorubicin rapid dissolution neutral [Epirubicin]
- 61% — Эпирубицин-Рус neutral [Epirubicin]
- 61% — Эпирубицин-Келун-Казфарм neutral [Epirubicin]
- 61% — Эпирубицин-РОНЦ neutral [Epirubicin]
- 61% — Epirubicin hydrochloride neutral [Epirubicin]
- 60% — Episindan neutral [Epirubicin]
- 57% 2.8-32.8€ Epirubicin-Ebewe neutral [Epirubicin]
- 55% 5.3-19.5€ Vero-Epirubicin neutral [Epirubicin]
- 51% — Proxifeine solution for injections neutral [Proxifeine]
- 51% — Proxifeine filmcoated tablets 0,25 g (enterosoluble) neutral [Proxifeine]
- 48% — Никорубин neutral [Doxorubicin]
- 48% 6.9€ Doxorubicin-Teva neutral [Doxorubicin]
- 48% — Doxorubicin-Ferein neutral [Doxorubicin]
- 48% — Doxorubicin Lachema neutral [Doxorubicin]
- 48% — Doxorubicin hydrochloride neutral [Doxorubicin]
- 48% — Rastocin neutral [Doxorubicin]
- 48% 2.6-7.7€ Doxorubicin-LANS neutral [Doxorubicin]
- 48% — Доксофос neutral [Doxorubicin]
- 46% 970€ Caelyx neutral [Doxorubicin]
- 46% 9.9€ Doxorubicin-Ebewe neutral [Doxorubicin]
- 45% 3.5€ Adriblastina rapid dissolution neutral [Doxorubicin]
- 45% — Doxolem neutral [Doxorubicin]
- 43% — Arglabine neutral
- 41% 2.6€ Doxorubicin neutral [Doxorubicin]
- 41% — Doxorubicin-RONC neutral [Doxorubicin]
- 41% — Doxorubicin-DEKO neutral [Doxorubicin]
- 41% — Adriblastina NovaMedica rapid dissolution neutral [Doxorubicin]
- 41% 3.6€ Sindroxocin neutral [Doxorubicin]
- 41% — Doxorubifer neutral [Doxorubicin]
- 38% 13.8-28.7€ Leukeran neutral [Chlorambucil]
- 38% — Chlorbutin neutral [Chlorambucil]
- 38% — Chlorbutin tablets neutral [Chlorambucil]
- 38% — Лорамил neutral [Chlorambucil]
- 36% 2.4€ Fytosid neutral [Etoposide]
- 36% — Cyclophosphamide neutral [Cyclophosphamide]
- 35% — Rubomycin hydrochloride neutral [Daunorubicin]
- 34% 43.9-46.4€ Sehydrin Dangerous 🔍 [Hydrazine sulfate]
- 31% — Rubomycin neutral [Daunorubicin]
- 30% 40.9-167€ Taxotere neutral [Docetaxel]
- 29% — Vero-Iphosfamide neutral [Ifosfamide]
- 29% — Iphosfamid neutral [Ifosfamide]
- 29% — Вескомид neutral [Ifosfamide]
- 28% 12.9€ Vero-Bleomycin neutral [Bleomycin]
- 28% 4400€ Lynparza neutral [Olaparib]
- 28% 15.7€ Bleocin neutral [Bleomycin and more 1Bleomycin sulfate]
- 28% — Bleomycetin hydrochloride neutral [Bleomycin]
- 28% 1.8€ Daunorubicin-LANS neutral [Daunorubicin]
Learn more about the selection of analogues
- The drug has «Oncotrone» 7 full analogs, the cheapest - Mitoxantron-LANS (23.4€); 51 analog by action, the most similar - Farmorubicin rapid dissolution (11.7€).
- Medical online service has selected the best substitutes for Oncotrone based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Oncotrone to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.